Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00556946 · ClinicalTrials.gov registry record · NA

Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains

A NA study, sponsored by University of California, Irvine.

Completed
Registry status
NA
Development phase
17
Enrollment target

NCT00556946 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 17 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00556946, a NA study, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

This research study was designed to determine the effect on port wine stains (PWS) of liposomal benzoporphyrin derivative monoacid (BPD-MA) termed verteporfin by intravenous (IV) infusion for photodynamic therapy (PDT) or combined PDT and pulsed dye laser (PDL) therapy (PDT + PDL). The standard treatment for PWS is PDL alone. This lightens some PWS but many lesions are not completely removed. PDT uses a medication and light together to cause injury to a target. The medication is given and then light is directed at the desired area of treatment to achieve an effect. PDT has been used to treat some skin conditions including pre-cancers and skin cancers. Using PDT or PDT immediately followed by PDL therapy may improve PWS lightening. At this time, both PDT and PDT + PDL therapy for treatment of PWS is investigational. The type and amount of medication and light which may be used to treat PWS is not known, and is likely to be different than those used for other PDT treatments.

Interventions

  • DRUG Combined Photodynamic & Pulsed Dye Laser Treatment

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2005-08
Est. Completion 2014-10
Phase NA

Sponsor

University of California, Irvine

368 total trials

What the Registry Record Tells You About NCT00556946

The ClinicalTrials.gov registry entry for NCT00556946 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Combined Photodynamic & Pulsed Dye Laser Treatment is the first listed.

NCT00556946 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00556946 about?

NCT00556946 is a clinical study titled "Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains". This research study was designed to determine the effect on port wine stains (PWS) of liposomal benzoporphyrin derivative monoacid (BPD-MA) termed verteporfin by intravenous (IV) infusion for photodynamic therapy (PDT) or combined PDT and pulsed dye laser (PDL) therapy (PDT + PDL). The standard trea...

What is the current status of trial NCT00556946?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2005-08. Estimated completion is 2014-10.

What interventions are being tested in trial NCT00556946?

The interventions under investigation include: Combined Photodynamic & Pulsed Dye Laser Treatment (DRUG).

Who is sponsoring clinical trial NCT00556946?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.